We are live on ! Find out more
CANC icon

Tema Oncology ETF
CANC

3 hedge funds and large institutions have $13.2M invested in Tema Oncology ETF in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

1.01% more ownership

Funds ownership: 25.84% → 26.85% (+1%)

4% more capital invested

Capital invested by funds: $12.6M → $13.2M (+$536K)

40% less funds holding

Funds holding: 5 → 3 (-2)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

Holders
3
Holders Change
-2
Holders Change %
-40%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans
Minnesota
+$3.21M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$54

Top Sellers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
-$1.26M
2
Osaic Holdings
Osaic Holdings
Arizona
-$5.68K
3
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$3K

CANC Hedge Fund Activity: Q4 2024 in Review

3 of the 7,613 institutional investors tracked by Wall St. Rank reported a position in Tema Oncology ETF (CANC) for Q4 2024, worth a combined $13.2M — up 4.2% from $12.6M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of CANC and 1 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 1 added.

The largest buyer was Thrivent Financial for Lutherans, adding an estimated $3.21M. The largest seller was Jane Street, exiting entirely with an estimated $1.26M sold.

  • 3 institutional investors held Tema Oncology ETF (CANC) as of Q4 2024, down from 5 in Q3 2024.
  • Funds reported $13.2M of Tema Oncology ETF stock for Q4 2024, up 4.2% quarter-over-quarter.
  • 1 fund opened new Tema Oncology ETF positions in Q4 2024 and 3 closed out, a net change of -2 holders.
  • The largest Tema Oncology ETF buyer in Q4 2024 was Thrivent Financial for Lutherans, an estimated $3.21M added.
  • The largest Tema Oncology ETF seller in Q4 2024 was Jane Street, an estimated $1.26M sold.

Based on aggregated 13F filings for Q4 2024.